06 August 2021>: Articles
Re-Challenging with Nivolumab in Metastatic Renal Cell Carcinoma After Immune-Related Interstitial Pneumonia: A Case Report
Unusual clinical course, Unusual or unexpected effect of treatment
Yosuke Shibata A* , Go Noguchi E , Takahisa Suzuki E , Kimito Osaka E , Susumu Umemoto E , Takeshi Kishida EDOI: 10.12659/AJCR.932924
Am J Case Rep 2021; 22:e932924
Figure 1. The CT scan shows left adrenal and lung metastases before initial nivolumab therapy (A), after 3 cycles of nivolumab therapy (B), and 7 months after nivolumab discontinuation (C).